Concentration of Risk

Merck & Co., Inc.

Medium

MRK · NYSE · Pharmaceutical Preparations · CIK 0000310158

Latest filing: · 2026-02-24

Customer concentration

Significant Customers note · revenue dependency

Low
Top exposure
<10%
No disclosure detected
Flat

Geographic concentration

Segment reporting · geographic revenue

High
Top exposure
56.2%
United StatesNamed
+5.9pp YoY

Click a point to open the SEC source

FY23FY24FY250%15%30%45%60%

Supplier concentration

Risk Factors · supply chain dependency

Low
Dependency
Diversified
Diversified
Flat

Qualitative dependency level by filing year.

Product concentration

ASC 275 · disclosed dependence on a specific product or service

High
Top exposure
49%
KeytrudaNamed
Flat

Click a point to open the SEC source

FY250%15%30%45%60%

Credit concentration

ASC 825 · concentration of credit risk note

Low
Receivables
22%
Mc Kesson Corporation
Flat

Click a point to open the SEC source

FY250%6%12%18%24%